16 August 2024
ECO Animal Health Group plc
("ECO" or the "Company")
Posting of the Annual Report and Notice of AGM
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that its Annual Report and Accounts for the year ended 31 March 2024 and Notice of Annual General Meeting ("AGM") together with Form of Proxy have today been sent to shareholders who have elected to receive hard copies by post.
The Annual Report and Accounts is available on the Company's website at https://ecoanimalhealth.com/investors/.
The Company will hold its AGM at The Grange, 100 High Street, London, N14 6BN on Thursday, 26 September 2024 at 9:00 am.
A copy of the Notice of AGM and Form of Proxy will be available on the Company's website at https://ecoanimalhealth.com/investors/.
-Ends-
For further information please contact:
| |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
